The reasons for triple therapy in stable COPD patients in Japanese clinical practice

BACKGROUND: Triple combination therapy involving long-acting muscarinic antagonists long-acting β(2) agonists, and inhaled corticosteroids has recently become an option for maintenance treatment of COPD. Some add-on clinical trials have reported the benefits of these combinations. However, the proce...

詳細記述

保存先:
書誌詳細
出版年:Int J Chron Obstruct Pulmon Dis
主要な著者: Miyazaki, Masaki, Nakamura, Hidetoshi, Takahashi, Saeko, Chubachi, Shotaro, Sasaki, Mamoru, Haraguchi, Mizuha, Terai, Hideki, Ishii, Makoto, Fukunaga, Koichi, Tasaka, Sadatomo, Soejima, Kenzo, Asano, Koichiro, Betsuyaku, Tomoko
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2015
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4461139/
https://ncbi.nlm.nih.gov/pubmed/26082629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S79864
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料